ARTICLE | Distillery Therapeutics
Musculoskeletal
August 29, 2018 5:52 PM UTC
Cell culture and mouse studies suggest inhibiting miR-23b and miR-218 could help treat DM1. In myoblast cells from a DM1 patient, miR-23b and miR-218 antagomirs decreased disease-associated splicing d...
BCIQ Company Profiles